A detailed history of Sbi Securities Co., Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 18,059 shares of MRNA stock, worth $631,703. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,059
Holding current value
$631,703
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

BUY
$36.85 - $63.93 $665,474 - $1.15 Million
18,059 New
18,059 $751 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $13.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sbi Securities Co., Ltd. Portfolio

Follow Sbi Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sbi Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sbi Securities Co., Ltd. with notifications on news.